Clive A. Meanwell
2015
In 2015, Clive A. Meanwell earned a total compensation of $5.2M as Chief Executive Officer at Medicines, which was about the same as previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $537,868 |
|---|---|
| Option Awards | $2,632,467 |
| Salary | $896,447 |
| Stock Awards | $1,124,993 |
| Other | $3,354 |
| Total | $5,195,129 |
Meanwell received $2.6M in option awards, accounting for 51% of the total pay in 2015.
Meanwell also received $537.9K in non-equity incentive plan, $896.4K in salary, $1.1M in stock awards and $3.4K in other compensation.
Rankings
In 2015, Clive A. Meanwell's compensation ranked 1,516th out of 13,638 executives tracked by ExecPay. In other words, Meanwell earned more than 88.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,516 out of 13,638 | 89th |
Division Manufacturing | 542 out of 5,187 | 90th |
Major group Chemicals And Allied Products | 201 out of 1,857 | 89th |
Industry group Drugs | 154 out of 1,531 | 90th |
Industry Pharmaceutical Preparations | 124 out of 1,179 | 90th |
Source: SEC filing on April 26, 2017.
Meanwell's colleagues
We found four more compensation records of executives who worked with Clive A. Meanwell at Medicines in 2015.